Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
37.4M
-
Number of holders
-
92
-
Total 13F shares, excl. options
-
26M
-
Shares change
-
-583K
-
Total reported value, excl. options
-
$275M
-
Value change
-
-$6.2M
-
Number of buys
-
37
-
Number of sells
-
-44
-
Price
-
$10.60
Significant Holders of LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) as of Q1 2021
99 filings reported holding LFCR - LIFECORE BIOMEDICAL, INC. DE - Common Stock as of Q1 2021.
LIFECORE BIOMEDICAL, INC. DE - Common Stock (LFCR) has 92 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 26M shares
of 37.4M outstanding shares and own 69.37% of the company stock.
Largest 10 shareholders include Legion Partners Asset Management, LLC (2.93M shares), WYNNEFIELD CAPITAL INC (2.91M shares), BlackRock Inc. (2.18M shares), DIMENSIONAL FUND ADVISORS LP (2.14M shares), VANGUARD GROUP INC (1.68M shares), Cove Street Capital, LLC (1.68M shares), HEARTLAND ADVISORS INC (1.23M shares), Russell Investments Group, Ltd. (1.18M shares), INVESTMENT COUNSELORS OF MARYLAND LLC (1.14M shares), and KENNEDY CAPITAL MANAGEMENT, INC. (1.12M shares).
This table shows the top 92 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.